Level Bio Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • LEVBIO

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.02
  • (As of Thursday Closing)

Level Bio General Information

Description

Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.

Contact Information

Website
www.levelbio.se
Formerly Known As
Picron Microarrays
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Västra Finnbodavägen 4B
  • Nacka
  • 131 30 Stockholm
  • Sweden
+46 08-626
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NGM
Vertical(s)
Corporate Office
  • Västra Finnbodavägen 4B
  • Nacka
  • 131 30 Stockholm
  • Sweden
+46 08-626

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Level Bio Stock Performance

As of 19-Nov-2026, Level Bio’s stock price is $0.02. Its current market cap is $1.65M with 68.4M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.02 - $0.06 $1.65M 68.4M 45.7K

Level Bio Financials Summary

As of 30-Sep-2026, Level Bio has a trailing 12-month revenue of $3.86M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,484 2,062 1,593
Revenue 3,859 3,294 2,373 2,455
EBITDA (46) (132) (558) (709)
Net Income 487 (360) (744) (892)
Total Assets 1,965 1,527 1,393 1,910
Total Debt 0 217 128 111
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Level Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Level Bio‘s full profile, request access.

Request a free trial

Level Bio Patents

Level Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170239653-A1 Device and method for conducting direct quantitative real time pcr Inactive 05-Feb-2016
US-9273351-B2 Device and method for conducting direct quantitative real time pcr Active 24-Sep-2010
US-20130157276-A1 Device and method for conducting direct quantitive real time pcr Active 24-Sep-2010
WO-2012037978-A1 New device and method for conducting direct quantitive real time pcr Inactive 24-Sep-2010
US-20060199261-A1 For a microtitreplate or an array of separate test tubes; cooling or heating gas or liquid is spread evenly around each well especially when centrifuging Active 19-Dec-2002 B01L9/523
To view Level Bio’s complete patent history, request access »

Level Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Level Bio Acquisitions (1)

Level Bio’s most recent deal was a Merger/Acquisition with CyberGene. The deal was made on 01-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CyberGene 01-Jun-2021 Merger/Acquisition Diagnostic Equipment
To view Level Bio’s complete acquisitions history, request access »

Level Bio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Distribution

Subindustry

Rank

Percentile

To view Level Bio’s complete esg history, request access »

Level Bio Exits (1)

Level Bio’s most recent exit was on 01-Jun-2021 from CyberGene. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
CyberGene 01-Jun-2021 Completed
To view Level Bio’s complete exits history, request access »

Level Bio Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Alphahelix Technologies Nacka, Sweden 2011
Techtum Lab Nacka, Sweden 1975

Level Bio FAQs

  • When was Level Bio founded?

    Level Bio was founded in 1998.

  • Where is Level Bio headquartered?

    Level Bio is headquartered in Stockholm, Sweden.

  • What is the size of Level Bio?

    Level Bio has 10 total employees.

  • What industry is Level Bio in?

    Level Bio’s primary industry is Biotechnology.

  • Is Level Bio a private or public company?

    Level Bio is a Public company.

  • What is Level Bio’s stock symbol?

    The ticker symbol for Level Bio is LEVBIO.

  • What is the current stock price of Level Bio?

    As of 19-Nov-2026 the stock price of Level Bio is $0.02.

  • What is the current market cap of Level Bio?

    The current market capitalization of Level Bio is $1.65M.

  • What is Level Bio’s current revenue?

    The trailing twelve month revenue for Level Bio is $3.86M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process